Does postpartum status impact your choice of chemotherapy regimen for young women with a HR+/HER2- invasive ductal carcinoma with 1-3 positive lymph nodes?

No, the postpartum state would not affect my choice of adjuvant chemotherapy in a node-positive patient with HR+/HER2- breast cancer. Would submit tissue for Oncotype analysis to determine if the regimen should include an anthracycline (for Oncotype >30); if not, would favor TC x6 with concurrent ov...